Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.
Taromi S, Lewens F, Arsenic R, Sedding D, Sänger J, Kunze A, Möbs M, Benecke J, Freitag H, Christen F, Kaemmerer D, Lupp A, Heilmann M, Lammert H, Schneider CP, Richter K, Hummel M, Siegmund B, Burger M, Briest F, Grabowski P.
Taromi S, et al. Among authors: kunze a.
Oncotarget. 2017 Sep 23;8(57):97061-97078. doi: 10.18632/oncotarget.21221. eCollection 2017 Nov 14.
Oncotarget. 2017.
PMID: 29228593
Free PMC article.